High Blood Sugar During Gemcitabine for Pancreatic Cancer
Elevated blood sugar is a recognized complication during gemcitabine-based chemotherapy for pancreatic cancer, driven by anti-nausea steroids, tumor-related insulin loss, and reduced physical activity. This guide explains what causes it, how it is monitored, and which dietary and clinical steps your care team may recommend.
Flying After Leukemia Remission: Managing Infection Risk
Leukemia survivors often want to travel once remission is confirmed. This article covers when your immune system may be ready for air travel, which precautions matter most, and how to approach the trip safely.
Speaking Anxiety After Oral Cancer: Rebuilding Confidence
Voice changes after oral cancer treatment affect more than how you sound. They can trigger speaking anxiety and social withdrawal that persist long after physical recovery has stabilized.
Lung Cancer Scan Schedule After Curative Treatment
After lung cancer treatment ends, regular CT scans continue for years. This article explains the ASCO-recommended schedule, what nodule findings can mean, and how to manage the anxiety that comes with waiting for results.
Leukemia Caregiver Burnout During Long-Term Monitoring
Years of leukemia remission monitoring create a quiet, sustained stress that many caregivers underestimate. This guide explains why burnout builds during this phase and what evidence-based steps can help prevent it.
Active Surveillance vs. Treatment in Prostate Cancer
A new prostate cancer diagnosis often raises an immediate question: start treatment now, or monitor closely and act only if the cancer changes? This guide explains the key differences between active surveillance, surgery, and radiation - and lists the questions worth raising with your oncology team.
Managing Night Sweats After Ovarian Cancer Chemo
Ovarian cancer treatment often triggers a sudden, permanent menopause that brings night sweats, hot flashes, and fragmented sleep. This article reviews non-hormonal, behavioral, and integrative approaches supported by clinical trial evidence.
Preventing Bone Loss During Aromatase Inhibitor Therapy
Aromatase inhibitors can cause significant bone loss over years of use. This article explains how to monitor bone density, what calcium and vitamin D doses may help, and when prescription antiresorptive agents may be worth discussing with your oncologist.
Return to Work After Lymphoma: Managing Fatigue and Brain Fog
Cancer-related fatigue and brain fog affect many lymphoma survivors long after treatment ends. This guide covers evidence-based strategies for returning to work and managing these lasting effects.
Protein Strategies to Prevent Muscle Loss During Colorectal Chemo
Colorectal cancer chemotherapy can trigger cachexia, a condition that breaks down muscle even when calorie intake appears adequate. This article explains the protein targets the current evidence supports and gives practical strategies for hitting them during active treatment.
